Detail akcie Cosmos Health Rg online

Business Summary: Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Cosmos Health Inc revenues increased 13% to $45.6M. Net loss applicable to common stockholders decreased 30% to $9M. Revenues reflect UK segment increase of 18% to $787K, Cyprus segment increase of 3% to $92K. Lower net loss reflects Sales and marketing expenses decrease of 65% to $115K (expense), Foreign currency transaction gain (loss) increase from $158K to $346K (income).